Maplight Therapeutics, INC. (MPLT) SEC Filings — 2026
4 SEC filings for Maplight Therapeutics, INC. (MPLT) in 2026.
Filings
- Maplight Therapeutics, INC. 144 Filing — 144 · Apr 15, 2026
- MapLight Therapeutics Files S-8 for Employee Stock Plans — S-8 · Mar 26, 2026
- MapLight's Lead Drug Nears Key Phase 2 Readouts for Schizophrenia, ADP — 10-K · Mar 26, 2026
- MapLight Therapeutics Files 8-K on Financial Results & Reg FD Disclosure — 8-K · Mar 26, 2026